相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polymorphism of the μ-Opioid Receptor Gene (OPRM1 118A>G) Affects Fentanyl-Induced Analgesia During Anesthesia and Recovery
Wei Dong Wu et al.
Molecular Diagnosis & Therapy (2012)
Initial Evidence of an Association Between OPRM1 and Adolescent Alcohol Misuse
Robert Miranda et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
Association of Mu-Opioid Receptor Variants and Response to Citalopram Treatment in Major Depressive Disorder
Holly A. Garriock et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Association of human μ-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients
W. Zhang et al.
ANAESTHESIA (2010)
Observational study of the effect of μ-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia
C. A. Wong et al.
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA (2010)
Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain
Kuang-I Cheng et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
A118G Polymorphism of OPRM1 Gene is Associated with Schizophrenia
Omar Sery et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators
Wendy Ooteman et al.
ADDICTION BIOLOGY (2009)
OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach
Gabor Oroszi et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
The Interaction of Reward Genes With Environmental Factors in Contribution to Alcoholism in Mexican Americans
Yanlei Du et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Association of polymorphism in the human μ-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception
Masahiro Matsunaga et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study
Y. Ginosar et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Nicotine Withdrawal Sensitivity, Linkage to chr6q26, and Association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) Sample
Jill Hardin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Relatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-allele
R. W. Wiers et al.
GENES BRAIN AND BEHAVIOR (2009)
Expansion of the human μ-opioid receptor gene architecture: novel functional variants
Svetlana A. Shabalina et al.
HUMAN MOLECULAR GENETICS (2009)
A Common Human μ-Opioid Receptor Genetic Variant Diminishes the Receptor Signaling Efficacy in Brain Regions Processing the Sensory Information of Pain
Bruno Georg Oertel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene
Jin Xu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Do genetic predictors of pain sensitivity associate with persistent widespread pain?
Kate L. Holliday et al.
MOLECULAR PAIN (2009)
Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain
Ene-choo Tan et al.
MOLECULAR PAIN (2009)
OPRM1 Gene Is Associated With BMI in Uyghur Population
Ling Xu et al.
OBESITY (2009)
Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery
Kenichi Fukuda et al.
PAIN (2009)
Meta-analysis of the relevance of the OPRM1 118A > G genetic variant for pain treatment
Carmen Walter et al.
PAIN (2009)
Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network
Charlotte A. Boettiger et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions
Ying-Xian Pan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior
Stephen D. Mague et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection
Baldwin M. Way et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients
Sung-Gon Kim et al.
PSYCHOPHARMACOLOGY (2009)
Effects of fentanyl on gastric myoelectrical activity:: a possible association with polymorphisms of the μ-opioid receptor gene?
J. Wallden et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2008)
Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes
Francesca M. Filbey et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers
Albert J. Arias et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska Natives and non-natives residing in rural settings: A randomized controlled trial
Stephanie S. O'Malley et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females
C. -J. Huang et al.
ANAESTHESIA (2008)
A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia
Alex T. Sia et al.
ANESTHESIOLOGY (2008)
An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence
Raymond F. Anton et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood
Kenneth A. Perkins et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers
Kenneth A. Perkins et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence
Johan Kakko et al.
BIOLOGICAL PSYCHIATRY (2008)
Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians
Cindy L. Ehlers et al.
BMC MEDICAL GENETICS (2008)
Association between μ-opioid receptor-1 102T>C polymorphism and intermediate type 2 diabetes phenotypes:: Results from the Quebec Family Study (QFS)
Stephanie-May Ruchat et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Association of candidate genes with antisocial drug dependence in adolescents
Robin P. Corley et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Genetic susceptibility to heroin addiction: a candidate gene association study
O. Levran et al.
GENES BRAIN AND BEHAVIOR (2008)
A functional polymorphism of the μ-opioid receptor gene is associated with completed suicides
A. Hishimoto et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Nicotine abstinence-induced cerebral blood flow changes by genotype
Ze Wang et al.
NEUROSCIENCE LETTERS (2008)
The mu opioid receptor A118G gene polymorphism moderates effects of trait anger-out on acute pain sensitivity
Stephen Bruehl et al.
PAIN (2008)
Genetic variability of the μ-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women
Ruth Landau et al.
PAIN (2008)
Association of morphine-induced antinociception with variations in the 5′ flanking and 3′ untranslated regions of the μ opioid receptor gene in 10 inbred mouse strains
Yoshihiro Shigeta et al.
PHARMACOGENETICS AND GENOMICS (2008)
Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype
Masakazu Hayashida et al.
PHARMACOGENOMICS (2008)
Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment
Severine Crettol et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief
D. Campa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment
Jennifer W. Tidey et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Population-specific effects 14OAsp polymorphism at the μ-opioid receptor gene of the As (OPRM1) on HPA-axis activation
Carlos A. Hernandez-Avila et al.
PHARMACOGENETICS AND GENOMICS (2007)
Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial
Riju Ray et al.
NICOTINE & TOBACCO RESEARCH (2007)
Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis
Stephen J. Glatt et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
The opioid system in alcohol and drug dependence: Family-based association study
Xiaoling Xuei et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Association of the mu-opioid receptor gene with smoking cessation
M. R. Munafo et al.
PHARMACOGENOMICS JOURNAL (2007)
Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response - A double-blind placebo-controlled study
Lara A. Ray et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain:: OPRM1 and COMT gene
Cielito C. Reyes-Gibby et al.
PAIN (2007)
The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference
Paul Marquez et al.
NEUROPHARMACOLOGY (2007)
The Asp40 μ-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers
Jennifer M. Mitchell et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population
Dandan Zhang et al.
BIOLOGICAL PSYCHIATRY (2007)
A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers
Esther van den Wildenberg et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
Characterizing exons II and I promoters of the mu opioid receptor (Oprm) gene in transgenic mice
Jin Xu et al.
BMC MOLECULAR BIOLOGY (2006)
Association of OPRM1 A118G variant with the relative reinforcing value of nicotine
R. Ray et al.
PSYCHOPHARMACOLOGY (2006)
No association of single nucleotide polymorphisms in the μ-opioid receptor subunit gene with idiopathic generalized epilepsy
Catherine Barratt et al.
EPILEPSIA (2006)
A genetic association study of the functional A118G polymorphism of the human μ-opioid receptor gene in patients with acute and chronic pain
Piotr K. Janicki et al.
ANESTHESIA AND ANALGESIA (2006)
The μ-opioid receptor gene polymorphism 118A > G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carries
Bruno G. Oertel et al.
PHARMACOGENETICS AND GENOMICS (2006)
Genetic moderators of naltrexone's effects on alcohol cue reactivity
John E. McGeary et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
Association of μ-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty
W. -Y. Chou et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2006)
Human opioid receptor A118G polymorphlism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy
Wen-Ying Chou et al.
ANESTHESIOLOGY (2006)
Association of an Asn40Asp (A118G) polymorphism in the μ-opioid receptor gene with substance dependence:: A meta-analysis
Albert Arias et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-1B4 in the mouse central nervous system
Yahong Zhang et al.
BRAIN RESEARCH (2006)
Intracisternal A-particle element in the 3′ noncoding region of the mu-opioid receptor gene in CXBK mice:: a new genetic mechanism underlying differences in opioid sensitivity
Wenhua Han et al.
PHARMACOGENETICS AND GENOMICS (2006)
μ opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers
Katarina Drakenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease
Judith A. Strong et al.
MOVEMENT DISORDERS (2006)
Relevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers
J. Lötsch et al.
PHARMACOGENOMICS JOURNAL (2006)
Linkage disequilibrium and association with methamphetamine dependence/psychosis of μ-opioid receptor gene polymorphisms
S. Ide et al.
PHARMACOGENOMICS JOURNAL (2006)
A clinical genetic method to identify mechanisms by which pain causes depression and anxiety
Mitchell B. Max et al.
MOLECULAR PAIN (2006)
Involvement of the 3′ non-coding region of the mu opioid receptor gene in morphine-induced analgesia
S Kasai et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2006)
Environmental and genetic factors associated with morphine response in the postoperative period
L Coulbault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Anger regulation style, postoperative pain, and relationship to the A118G mu opioid receptor gene polymorphism: A preliminary study
S Bruehl et al.
JOURNAL OF BEHAVIORAL MEDICINE (2006)
Association between two μ-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence
HP Zhang et al.
HUMAN MOLECULAR GENETICS (2006)
Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action
J Lotsch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population
Daisuke Nishizawa et al.
NEUROPSYCHOBIOLOGY (2006)
Association of the mu-opioid receptor gene with type 2 diabetes mellitus in an African American population
CJ Gallagher et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Characterization of the 3′ untranslated region of the human mu-opioid receptor (MOR-1) mRNA
S Ide et al.
GENE (2005)
Clinical response to morphine in cancer patients and genetic variation in candidate genes
JR Ross et al.
PHARMACOGENOMICS JOURNAL (2005)
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
How individual sensitivity to opiates can be predicted by gene analyses
K Ikeda et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Polymorphism of μ-opioid receptor gene (OPRM1:c.118A >G) does not protect against opioid-induced respiratory depression despite reduced analgesic response
RR Romberg et al.
ANESTHESIOLOGY (2005)
The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans
RB Fillingim et al.
JOURNAL OF PAIN (2005)
Novel exonic μ-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence
RJ Smith et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Increased attributable risk related to a functional μ-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden
G Bart et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm
L Pan et al.
NEUROSCIENCE (2005)
Loss of nicotine-induced behavioral sensitization in μ-opioid receptor knockout mice
JH Yoo et al.
SYNAPSE (2004)
μ-opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion
FS Hall et al.
MOLECULAR BRAIN RESEARCH (2004)
A polymorphism of the μ-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans
LA Ray et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
Association of functional opioid receptor genotypes with alcohol dependence in Koreans
SG Kim et al.
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers - Absence of sex differences
R Romberg et al.
ANESTHESIOLOGY (2004)
Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in mouse brain
C Abbadie et al.
NEUROSCIENCE (2004)
Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han
EW Loh et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
The 118 A > G polymorphism in the human μ-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
P Klepstad et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2004)
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden
G Bart et al.
MOLECULAR PSYCHIATRY (2004)
Association study of personality factors and the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1)
CA Hernandez-Avila et al.
PSYCHIATRIC GENETICS (2004)
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial
C Lerman et al.
PHARMACOGENOMICS JOURNAL (2004)
μ opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics
N Urraca et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
What place does naltrexone have in the treatment of alcoholism?
DJ Rohsenow
CNS DRUGS (2004)
Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor
A Beyer et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Association of polymorphisms in nicotinic acetylcholine receptor α4 subunit gene (CHRNA4), μ-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients
SA Kim et al.
ALCOHOL (2004)
A genetic association study of the mu opioid receptor and severe opioid dependence
JJ Crowley et al.
PSYCHIATRIC GENETICS (2003)
Association between human μ-opioid receptor gene polymorphism, pain tolerance, and opioid addiction
P Compton et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
A functional polymorphism of the μ-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients
DW Oslin et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy
T Hirota et al.
DRUG METABOLISM AND DISPOSITION (2003)
Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ-opioid receptor locus (OPRM1)
CA Hernandez-Avila et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations
EC Tan et al.
NEUROREPORT (2003)
Introducing a new recruitment approach to sample collection for genetic association studies in opioid dependence
P Franke et al.
EUROPEAN PSYCHIATRY (2003)
Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers
C Skarke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice
A Castane et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia
EC Tan et al.
SCHIZOPHRENIA RESEARCH (2003)
被撤回的出版物: Association of μ-opioid receptor subunit gene and idiopathic generalized epilepsy (Retracted Article. See vol. 64, pg 579, 2005)
H Wilkie et al.
NEUROLOGY (2002)
Lack of association of a single-nucleotide polymorphism of the μ-opioid receptor gene with anxiety-related traits:: Results from a cross-sectional study of adults and a longitudinal study of children
AF Jorm et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Lack of reward and locomotor stimulation induced by heroin in μ-opioid receptor-deficient mice
A Contarino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Hypothalamic-pituitary-adrenocorticaI (HPA) axis response and biotransformation of oral naltrexone: Preliminary examination of relationship to family history of alcoholism
AC King et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism
CA Hernandez-Avila et al.
BIOLOGICAL PSYCHIATRY (2002)
Rewarding effects of ethanol and cocaine in μ opioid receptor-deficient mice
A Becker et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2002)
Exploring the opioid system by gene knockout
BL Kieffer et al.
PROGRESS IN NEUROBIOLOGY (2002)
Sequence Variations in the Mu-opioid Receptor Gene (OPRM1) Associated with Human Addiction to Heroin
Jinxiu Shi et al.
HUMAN MUTATION (2002)
The Mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade
GS Wand et al.
NEUROPSYCHOPHARMACOLOGY (2002)
A functional polymorphism gene and risk for abuse of within the mu-opioid receptor alcohol and other substances
JA Schinka et al.
MOLECULAR PSYCHIATRY (2002)
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine
J Lotsch et al.
PHARMACOGENETICS (2002)
Polymorphisms of μ and δ opioid receptor genes and tardive dyskinesia in patients with schizophrenia
O Ohmori et al.
SCHIZOPHRENIA RESEARCH (2001)
Genetic analysis of the μ-opioid receptor in alcohol-dependent individuals
H Rommelspacher et al.
ALCOHOL (2001)
Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts
CYK Szeto et al.
NEUROREPORT (2001)
A single nucleotide polymorphic mutation in the human μ-opioid receptor severely impairs receptor signaling
K Befort et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Ethanol consumption and reward are decreased in μ-opiate receptor knockout mice
FS Hall et al.
PSYCHOPHARMACOLOGY (2001)
Tissue distribution and pharmacological potential of SM-16896, a novel oestrogen-bisphosphonate hybrid compound
N Tsushima et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Genetic variation of the human mu-opioid receptor and susceptibility to idiopathic absence epilepsy
T Sander et al.
EPILEPSY RESEARCH (2000)
分享论文
